GSK plc
GSK
#221
Rank
NZ$173.56 B
Marketcap
NZ$86.49
Share price
-0.53%
Change (1 day)
34.99%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2026 (TTM): NZ$6.64

According to GSK plc's latest financial reports the company's current EPS (TTM) is NZ$6.62. In 2025 the company made an earnings per share (EPS) of NZ$6.42 an increase over its 2024 EPS that were of NZ$2.72.

EPS history for GSK plc from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.643.42%
2025NZ$6.42136.36%
2024NZ$2.72-47.35%
2023NZ$5.16-64.2%
2022NZ$14.41182.29%
2021NZ$5.10-18.07%
2020NZ$6.2322.34%
2019NZ$5.0923.9%
2018NZ$4.11140.61%
2017NZ$1.7164.45%
2016NZ$1.04-90.61%
2015NZ$11.06178.12%
2014NZ$3.98-48.11%
2013NZ$7.6622.68%
2012NZ$6.25-11.31%
2011NZ$7.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.96 80.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.23-66.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.36-34.14%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$6.06-8.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.84 78.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.33-64.75%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ-$0.55-108.23%๐Ÿ‡บ๐Ÿ‡ธ USA